Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer.

EJNMMI research·2026
Same author

Ventricular Pacing-Triggered Echo Beats via a Decremental Concealed Fasciculoventricular Pathway: Diagnosed on Surface Electrocardiogram.

JACC. Clinical electrophysiology·2026
Same author

Narrow QRS Tachycardia With a His-A-V Sequence and Fixed Short HA Interval: A Concealed Nodofascicular Circuit With a Bystander Atrio-Hisian Tract.

JACC. Clinical electrophysiology·2026
Same author

Transcriptome Comparison Between the Cultured and In Vivo Chick Primordial Germ Cells by SMART-Seq-Based Single-Cell RNA Sequencing.

Development, growth & differentiation·2026
Same author

REPLY: Sketches Need to Reflect Anatomy to Create Realistic and Believable Figures.

JACC. Clinical electrophysiology·2026
Same author

Irregular A-H-V-H-V Pattern Arrhythmia: Dual Atrioventricular Nodal Conduction vs Concealed Fasciculoventricular Pathway-Mediated Re-Entry.

JACC. Clinical electrophysiology·2026

Related Experiment Video

Updated: May 31, 2026

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

Biopathways representation and simulation on hybrid functional petri net.

Hiroshi Matsuno1, Yukiko Tanaka, Hitoshi Aoshima

  • 1Faculty of Science, Yamaguchi University, Yamaguchi, Japan.

Studies in Health Technology and Informatics
|June 21, 2011
PubMed
Summary

This study introduces Hybrid Functional Petri Nets (HFPN) and the Genomic Object Net software for intuitive biological pathway simulation. These tools aim to improve user acceptance of biosimulation by focusing on biological relevance and ease of use.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression
11:23

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Related Experiment Videos

Last Updated: May 31, 2026

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression
11:23

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Area of Science:

  • Computational Biology
  • Systems Biology
  • Bioinformatics

Background:

  • Current biosimulation tools face challenges in user acceptance due to irrelevant complexities and difficulties in intuitive representation and management of biological pathways.
  • Addressing these limitations is crucial for the widespread adoption of computational tools in biological and medical research.

Purpose of the Study:

  • To develop a novel Petri net framework, Hybrid Functional Petri Net (HFPN), addressing key user-acceptance criteria for biosimulation.
  • To introduce the Genomic Object Net software, built upon HFPN, for intuitive representation and simulation of biological pathways.
  • To demonstrate the utility of the developed tool through case studies of complex biological mechanisms.

Main Methods:

  • Definition of a novel Petri net concept: Hybrid Functional Petri Net (HFPN).
  • Development of the Genomic Object Net software utilizing the HFPN architecture.
  • Application of HFPN for modeling gene regulation in Drosophila melanogaster circadian rhythm and Fas ligand-induced apoptosis.

Main Results:

  • Successful representation of complex biological pathways using the HFPN framework.
  • The Genomic Object Net software effectively simulates these pathways.
  • Simulation outcomes correlate well with established biological observations for the studied mechanisms.

Conclusions:

  • The Hybrid Functional Petri Net (HFPN) provides an intuitive and biologically relevant approach for biosimulation.
  • Genomic Object Net, based on HFPN, is a useful tool for representing and simulating biological pathways.
  • The developed software and methodology enhance the potential for broader acceptance and application of biosimulation tools in biology and medicine.